D. Hackett

2.9k total citations
55 papers, 2.0k citations indexed

About

D. Hackett is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Experimental and Cognitive Psychology. According to data from OpenAlex, D. Hackett has authored 55 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cardiology and Cardiovascular Medicine, 15 papers in Pharmacology and 14 papers in Experimental and Cognitive Psychology. Recurrent topics in D. Hackett's work include Treatment of Major Depression (15 papers), Cardiac Imaging and Diagnostics (13 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (13 papers). D. Hackett is often cited by papers focused on Treatment of Major Depression (15 papers), Cardiac Imaging and Diagnostics (13 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (13 papers). D. Hackett collaborates with scholars based in United Kingdom, France and United States. D. Hackett's co-authors include A Maseri, G. Davies, G.J. Davies, J C Kaski, S Larkin, Graham J. Davies, Guido Magni, Peter Bogaty, Philippe Danjou and K A Hallidie-Smith and has published in prestigious journals such as The Lancet, Circulation and European Heart Journal.

In The Last Decade

D. Hackett

53 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Hackett United Kingdom 22 881 666 542 348 246 55 2.0k
Mark L. Dyken United States 26 1.1k 1.3× 185 0.3× 318 0.6× 157 0.5× 926 3.8× 55 2.5k
Stuart D. Rosen United Kingdom 28 1.4k 1.6× 740 1.1× 370 0.7× 59 0.2× 388 1.6× 94 2.6k
Joel A. Kaplan United States 29 1.3k 1.5× 289 0.4× 1.2k 2.3× 36 0.1× 341 1.4× 143 2.5k
Markus F. Stevens Netherlands 25 294 0.3× 252 0.4× 1.4k 2.5× 266 0.8× 141 0.6× 92 2.5k
Ernest V. Gervino United States 22 667 0.8× 256 0.4× 316 0.6× 71 0.2× 122 0.5× 44 2.1k
Kenji Nakashima Japan 16 236 0.3× 120 0.2× 154 0.3× 77 0.2× 140 0.6× 65 1.6k
G. Neil‐Dwyer United Kingdom 30 743 0.8× 272 0.4× 544 1.0× 50 0.1× 201 0.8× 67 2.7k
Steven G. Gourlay United States 18 423 0.5× 213 0.3× 193 0.4× 83 0.2× 85 0.3× 39 1.5k
Arshed A. Quyyumi United States 12 846 1.0× 296 0.4× 368 0.7× 35 0.1× 137 0.6× 21 1.5k
Narda D. Croughwell United States 24 1.3k 1.4× 184 0.3× 936 1.7× 26 0.1× 400 1.6× 59 2.3k

Countries citing papers authored by D. Hackett

Since Specialization
Citations

This map shows the geographic impact of D. Hackett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Hackett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Hackett more than expected).

Fields of papers citing papers by D. Hackett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Hackett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Hackett. The network helps show where D. Hackett may publish in the future.

Co-authorship network of co-authors of D. Hackett

This figure shows the co-authorship network connecting the top 25 collaborators of D. Hackett. A scholar is included among the top collaborators of D. Hackett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Hackett. D. Hackett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kojodjojo, Pipin, Diane Barker, Pouya Youssefi, et al.. (2008). Outcomes of elderly patients aged 80 and over with symptomatic, severe aortic stenosis: impact of patient's choice of refusing aortic valve replacement on survival. QJM. 101(7). 567–573. 55 indexed citations
2.
3.
Silverstone, Peter H., Richard Entsuah, & D. Hackett. (2002). Two items on the Hamilton Depression rating scale are effective predictors of remission: comparison of selective serotonin reuptake inhibitors with the combined serotonin/norepinephrine reuptake inhibitor, venlafaxine. International Clinical Psychopharmacology. 17(6). 273–280. 18 indexed citations
4.
Boyer, P, Vincent Mahé, D. Hackett, & V. Haudiquet. (2000). Efficacy of venlafaxine ER in social adjustment in patients with generalized anxiety disorder. European Neuropsychopharmacology. 10. 336–336. 1 indexed citations
5.
Hackett, D.. (2000). Venlafaxine XR in the treatment of anxiety. Acta Psychiatrica Scandinavica. 102(s406). 30–35. 14 indexed citations
6.
Mahé, Vincent, V. Haudiquet, D. Hackett, & Eliseo Salinas. (1999). An assessment of the efficacy of venlafaxine extended-release in elderly patients with generalized anxiety disorder. European Neuropsychopharmacology. 9. 316–316. 1 indexed citations
7.
Hackett, D., Virginia Parks, & Eliseo Salinas. (1998). Open-label evaluation of once-daily venlafaxine XR in depressed outpatients. European Neuropsychopharmacology. 8. S197–S197. 1 indexed citations
8.
Lecrubier, Y., Michel Bourin, C. A. L. Moon, et al.. (1997). Efficacy of venlafaxine in depressive illness in general practice. Acta Psychiatrica Scandinavica. 95(6). 485–493. 64 indexed citations
9.
Entsuah, A.R., et al.. (1996). Efficacy of venlafaxine and placebo during long-term treatment of depression: a pooled analysis of relapse rates. International Clinical Psychopharmacology. 11(2). 137–145. 44 indexed citations
10.
Danjou, Philippe & D. Hackett. (1995). Safety and tolerance profile of venlafaxine. International Clinical Psychopharmacology. 10. 15–20. 55 indexed citations
11.
Blanchard, Carine, D. Hackett, P. Danjou, & Timothy Nicholas. (1995). P-2-99 A randomized double-blind comparison of venlafaxine, imipramine and placebo in general practice patients with mild moderate depression. European Neuropsychopharmacology. 5(3). 308–308. 2 indexed citations
12.
Salinas, Eliseo, Timothy Nicholas, & D. Hackett. (1995). P-2-98 A randomised, double-blind, comparison of the efficacy and safety of venlafaxine (75 to 150 mg/day) versus fluoxetine (20 mg/day) in depressed outpatients. European Neuropsychopharmacology. 5(3). 308–308. 1 indexed citations
13.
Simon, Krzysztof, et al.. (1994). The natural history of postischemic T-wave inversion: a predictor of poor short-term prognosis?. PubMed. 5(11). 937–42. 10 indexed citations
14.
Andreotti, Felicita, D. Hackett, Maria Carla Roncaglioni, et al.. (1992). Von Willebrand Factor, Plasminogen Activator Inhibitor-1 and C-Reactive Protein Are Markers of Thrombolytic Efficacy in Acute Myocardial Infarction. Thrombosis and Haemostasis. 68(6). 678–682. 17 indexed citations
15.
Magni, Guido & D. Hackett. (1992). AN OPEN-LABEL EVALUATION OF THE LONG-TERM SAFETY AND CLINICAL ACCEPTABILITY OF VENLAFAXINE IN DEPRESSED PATIENTS.. Clinical Neuropharmacology. 15. 323B–323B. 3 indexed citations
16.
Chierchia, Sergio, et al.. (1990). Combined effects of nitrates on the coronary and peripheral circulation in exercise-induced ischemia.. Circulation. 81(6). 1881–1886. 6 indexed citations
17.
Hackett, D. & Hassan El‐Tamimi. (1989). Holter monitoring after PTCA. European Heart Journal. 10(suppl G). 33–35. 1 indexed citations
18.
Hackett, D., G.J. Davies, & A Maseri. (1988). Pre-existing coronary stenoses in patients with first myocardial infarction are not necessarily severe. European Heart Journal. 9(12). 1317–1323. 202 indexed citations
19.
Hackett, D., G. Davies, & A Maseri. (1988). Coronary constriction in acute myocardial infarction: role of nitrates. European Heart Journal. 9(suppl A). 151–153. 30 indexed citations
20.
Nihoyannopoulos, Petros, et al.. (1986). Left atrial myxoma: new perspectives in the diagnosis of murmur free cases.. Heart. 56(6). 554–560. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark L. Dyken Breakdown of academic impact, for papers by Stuart D. Rosen Breakdown of academic impact, for papers by Joel A. Kaplan Breakdown of academic impact, for papers by Markus F. Stevens Breakdown of academic impact, for papers by Ernest V. Gervino Breakdown of academic impact, for papers by Kenji Nakashima Breakdown of academic impact, for papers by G. Neil‐Dwyer Breakdown of academic impact, for papers by Steven G. Gourlay Breakdown of academic impact, for papers by Arshed A. Quyyumi Breakdown of academic impact, for papers by Narda D. Croughwell
Rankless by CCL
2026